While our previous studies have demonstrated the regulation of glycolytic metabolism in pancreatic cancer or glutamine metabolism in triple-negative breast cancer, our results from this study shed light on the functional implications of the MUC1 oncoprotein in pancreatic cancer progression through the regulation of polyamine biosynthesis (6, 8). The gene discussed is MUC1; the disease is pancreatic neoplasm.